Could TopBuild be the hidden gem you've been searching for in the construction industry? Tune in as our experts break down its strengths and weaknesses.
Keeping a home clean requires more than just basic sweeping and dusting. Modern households face daily challenges such as pet hair, food crumbs, dust buildup, muddy footprints, and stubborn floor stains. In 2026, vacuum cleaners have become smarter and more efficient, helping homeowners save time while maintaining cleaner and healthier living spaces. Advanced cleaning technology [...]
CapsoVision (NASDAQ:CV) reported steady first-quarter revenue and said it continues to advance artificial intelligence and capsule endoscopy programs aimed at expanding the use of its gastrointestinal imaging platform.
On the company’s first-quarter 2026 earnings call, President and Chief Executive
Biogen (NASDAQ:BIIB) is continuing to position immunology as a larger part of its strategy, with late-stage lupus and kidney disease programs expected to shape the company’s next phase of growth, Adam Meyers, head of the company’s immunology and new disease areas franchise, said at Bank of America’s
Celcuity (NASDAQ:CELC) reported a wider first-quarter loss as the biotechnology company increased spending tied to commercial launch preparations and continued development of gedatolisib, its investigational therapy for hormone receptor-positive, HER2-negative advanced breast cancer.
On the company
CuriosityStream (NASDAQ:CURI) reported a slight year-over-year increase in first-quarter revenue and reiterated that it is prioritizing larger licensing opportunities, particularly around artificial intelligence datasets, even as that approach contributed to uneven quarterly results.
On the company
Amid an uncertain economic backdrop, this high-quality dividend stock's reliable payouts and attractive yield can help investors generate stable returns while reducing overall portfolio risk.
